17376966|t|Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid.
17376966|a|Cerebral microvascular amyloid beta protein (Abeta) deposition and associated neuroinflammation is increasingly recognized as an important component leading to cognitive impairment in Alzheimer's disease and related cerebral amyloid angiopathy disorders. Transgenic mice expressing the vasculotropic Dutch/Iowa (E693Q/D694N) mutant human Abeta precursor protein in brain (Tg-SwDI) accumulate abundant cerebral microvascular fibrillar amyloid deposits and exhibit robust neuroinflammation. In the present study, we investigated the effect of the anti-inflammatory drug minocycline on Abeta accumulation, neuroinflammation, and behavioral deficits in Tg-SwDI mice. Twelve-month-old mice were treated with saline or minocycline by intraperitoneal injection every other day for a total of 4 weeks. During the final week of treatment, the mice were tested for impaired learning and memory. Brains were then harvested for biochemical and immunohistochemical analysis. Minocycline treatment did not alter the cerebral deposition of Abeta or the restriction of fibrillar amyloid to the cerebral microvasculature. Similarly, minocycline-treated Tg-SwDI mice exhibited no change in the levels of total Abeta, the ratios of Abeta40 and Abeta42, or the amounts of soluble, insoluble, or oligomeric Abeta compared with the saline-treated control Tg-SwDI mice. In contrast, the numbers of activated microglia and levels of interleukin-6 were significantly reduced in minocycline-treated Tg-SwDI mice compared with saline-treated Tg-SwDI mice. In addition, there was a significant improvement in behavioral performance of the minocycline-treated Tg-SwDI mice. These finding suggest that anti-inflammatory treatment targeted for cerebral microvascular amyloid-induced microglial activation can improve cognitive deficits without altering the accumulation and distribution of Abeta.
17376966	0	11	Minocycline	Chemical	MESH:D008911
17376966	55	74	behavioral deficits	Disease	MESH:D019958
17376966	100	130	cerebral microvascular amyloid	Disease	MESH:D016657
17376966	132	162	Cerebral microvascular amyloid	Disease	MESH:D016657
17376966	177	182	Abeta	Gene	11820
17376966	210	227	neuroinflammation	Disease	MESH:D000090862
17376966	292	312	cognitive impairment	Disease	MESH:D003072
17376966	316	335	Alzheimer's disease	Disease	MESH:D000544
17376966	348	385	cerebral amyloid angiopathy disorders	Disease	MESH:D016657
17376966	398	402	mice	Species	10090
17376966	444	449	E693Q	ProteinMutation	tmVar:p|SUB|E|693|Q;HGVS:p.E693Q;VariantGroup:0;CorrespondingGene:351;RS#:63750579;CorrespondingSpecies:9606;CA#:127790
17376966	450	455	D694N	ProteinMutation	tmVar:p|SUB|D|694|N;HGVS:p.D694N;VariantGroup:1;CorrespondingGene:351;RS#:63749810;CorrespondingSpecies:9606;CA#:127804
17376966	464	469	human	Species	9606
17376966	470	475	Abeta	Gene	351
17376966	507	511	SwDI	Disease	
17376966	542	555	microvascular	Disease	MESH:D017566
17376966	566	573	amyloid	Disease	MESH:C000718787
17376966	602	619	neuroinflammation	Disease	MESH:D000090862
17376966	682	694	inflammatory	Disease	MESH:D007249
17376966	700	711	minocycline	Chemical	MESH:D008911
17376966	715	720	Abeta	Gene	11820
17376966	735	752	neuroinflammation	Disease	MESH:D000090862
17376966	758	777	behavioral deficits	Disease	MESH:D019958
17376966	784	788	SwDI	Disease	
17376966	789	793	mice	Species	10090
17376966	812	816	mice	Species	10090
17376966	845	856	minocycline	Chemical	MESH:D008911
17376966	966	970	mice	Species	10090
17376966	987	1015	impaired learning and memory	Disease	MESH:D007859
17376966	1094	1105	Minocycline	Chemical	MESH:D008911
17376966	1157	1162	Abeta	Gene	11820
17376966	1195	1202	amyloid	Disease	MESH:C000718787
17376966	1248	1259	minocycline	Chemical	MESH:D008911
17376966	1271	1275	SwDI	Disease	
17376966	1276	1280	mice	Species	10090
17376966	1324	1329	Abeta	Gene	11820
17376966	1418	1423	Abeta	Gene	11820
17376966	1468	1472	SwDI	Disease	
17376966	1473	1477	mice	Species	10090
17376966	1541	1554	interleukin-6	Gene	16193
17376966	1585	1596	minocycline	Chemical	MESH:D008911
17376966	1608	1612	SwDI	Disease	
17376966	1613	1617	mice	Species	10090
17376966	1650	1654	SwDI	Disease	
17376966	1655	1659	mice	Species	10090
17376966	1743	1754	minocycline	Chemical	MESH:D008911
17376966	1766	1770	SwDI	Disease	
17376966	1771	1775	mice	Species	10090
17376966	1809	1821	inflammatory	Disease	MESH:D007249
17376966	1845	1875	cerebral microvascular amyloid	Disease	MESH:D016657
17376966	1918	1936	cognitive deficits	Disease	MESH:D003072
17376966	1991	1996	Abeta	Gene	11820
17376966	Negative_Correlation	MESH:D008911	MESH:D007859
17376966	Association	MESH:D003072	11820
17376966	Negative_Correlation	MESH:D008911	MESH:D019958
17376966	Association	MESH:D016657	RS#:63749810;HGVS:p.D694N;CorrespondingGene:351
17376966	Association	MESH:D016657	RS#:63750579;HGVS:p.E693Q;CorrespondingGene:351
17376966	Association	MESH:D000090862	11820
17376966	Negative_Correlation	MESH:D008911	MESH:D016657
17376966	Negative_Correlation	MESH:D008911	16193
17376966	Negative_Correlation	MESH:D008911	MESH:D007249
17376966	Association	MESH:D016657	351
17376966	Association	MESH:D016657	11820
17376966	Association	MESH:D016657	351

